US62857J2015 - Common Stock
MYOMO INC
NYSEARCA:MYO (4/19/2024, 9:57:02 AM)
3.01
+0.19 (+6.74%)
Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.
MYOMO INC
137 Portland Street, 4th Floor
Boston MASSACHUSETTS 02114
P: 16179969058
CEO: Paul R. Gudonis
Employees: 100
Website: https://myomo.com/
MYO stock results show that Myomo missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Here you can normally see the latest stock twits on MYO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: